WuXi plant passes FDA inspection; Algorithme partners up for patient recruitment;

> CRO Algorithme Pharma has inked a deal with the the University of Montreal Hospital Research Centre to provide patients for clinical trials. News

> WuXi PharmaTech's ($WX) Chinese small molecule API and advanced intermediate manufacturing facility passed an FDA inspection, according to the company. More

> Thanks to investments and hirings in Wilmington, NC, PPD is in line for as much as $125,000 in annual incentives from the local government. Article

Suggested Articles

Major CRO player Pharmaceutical Product Development is set to go back on the public markets after announcing its IPO plans.

Dubbed “Project Nightingale,” the efforts were announced amid concerns and federal inquiries into the data’s safekeeping and patient consent for use.

Independent site management organization Panthera Biopartners has kick-started its first clinical trial in the U.K.